Ignite Creation Date:
2024-05-06 @ 7:32 AM
Last Modification Date:
2024-10-26 @ 11:49 AM
Study NCT ID:
NCT02551315
Status:
COMPLETED
Last Update Posted:
2022-12-22
First Post:
2015-08-25
Brief Title:
Microarchitecture Bone Strength and Fracture Risk in Type 2 Diabetes
Sponsor:
University Hospital Basel Switzerland
Organization:
University Hospital Basel Switzerland
Study Overview
Official Title:
Microarchitecture Bone Strength and Fracture Risk in Type 2 Diabetes the DiabOS Study
Status:
COMPLETED
Status Verified Date:
2022-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DiabOS
Brief Summary:
This multicenter prospective observational cohort study will assess bone differences in women and men with type 2 diabetes mellitus T2DM with and without fragility fractures
Detailed Description:
Cross-sectional evaluation of clinical biochemical and microstructural measures of bone in patients with type 2 diabetes and age-matched healthy controls Longitudinal assessment of clinical biochemical and microstructural measures of bone in study participants without prevalent fragility fractures
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None